School of Medicine, Dentistry & Biomedical Sciences PhD Studentships - Apply Now
The School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast trains numerous PhD students in the areas of Cancer Research, Experimental Medicine and Public Health. Its diverse postgraduate student population comprises both basic and clinical scientists from across the globe engaged in wide-ranging research projects spanning the breadth of the School’s research portfolio from bioinformatics through molecular and cell biology to clinical trials. Students in the School benefit from world-class infrastructure and academic faculty together with provision of a tailored training programme, delivered in conjunction with the Graduate School, comprising both discipline-specific and generic skills, to effectively promote their education, professional development and career progression.
The School is pleased to offer a broad portfolio of PhD studentship projects for 2023/24 fully-funded by the Northern Ireland Department for the Economy in its 3 main research centres:
The Centre for Public Health is committed to identifying the epidemiological and genetic risk factors that are important for the health of the individual and of the population and to the development of screening and interventions to reduce the burden of chronic diseases in the future. This is achieved by advancing the health of the public at a regional, national and international level and increasing knowledge and influencing clinical and public health practice and policy. The Centre comprises four main research groups, focussing on Cancer Epidemiology, Epidemiology & Public Health, Health Services & Global Health and Public Health Nutrition.
The Patrick G Johnston Centre for Cancer specialises in integrating academic discovery, industrial/commercial enterprise and innovative health care practice to promote effective delivery of precision cancer medicine and to improve patient health and outcomes. The Centre comprises established multi-disciplinary teams focusing on cancers of gastrointestinal, prostate, breast and ovarian origin, with specific expertise in biomarker discovery and bioinformatics, biological investigation and therapeutic development, and early-phase clinical trials.
The Wellcome Wolfson Institute for Experimental Medicine drives scientific breakthroughs in the mechanisms of disease, translated to innovative therapeutics to improve patient outcomes, making important impacts against conditions such as diabetes, infection, and diseases of the eye and cardiovascular and respiratory systems. The Institute has a core emphasis on immunology, molecular cell biology and patient-based investigations, and comprises three main research themes focussed on Immunology and Microbes, Respiratory Medicine, and Vision and Vascular Medicine.
Continue with Facebook
